Cargando…

Development and validation of a self-management scale of type 1 diabetes for Chinese adults

OBJECTIVE: Self-management is beneficial for improving health outcomes in adults with type 1 diabetes. However, there are no validated instruments to assess self-management in Chinese adults with type 1 diabetes. The aim of this study was to develop and validate the Self-Management of Type 1 Diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Song, Liu, Fang, Li, Jina, Guan, Yuzhu, Meng, Meng, Li, Xia, Zhou, Zhiguang, Xu, Rong, Li, Lezhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469726/
https://www.ncbi.nlm.nih.gov/pubmed/32865059
http://dx.doi.org/10.1177/0300060520947588
_version_ 1783578451797606400
author Zhu, Song
Liu, Fang
Li, Jina
Guan, Yuzhu
Meng, Meng
Li, Xia
Zhou, Zhiguang
Xu, Rong
Li, Lezhi
author_facet Zhu, Song
Liu, Fang
Li, Jina
Guan, Yuzhu
Meng, Meng
Li, Xia
Zhou, Zhiguang
Xu, Rong
Li, Lezhi
author_sort Zhu, Song
collection PubMed
description OBJECTIVE: Self-management is beneficial for improving health outcomes in adults with type 1 diabetes. However, there are no validated instruments to assess self-management in Chinese adults with type 1 diabetes. The aim of this study was to develop and validate the Self-Management of Type 1 Diabetes for Chinese Adults (SMOD-CA) scale. METHODS: Qualitative and quantitative methods were used to develop the SMOD-CA. We conducted a literature review and semi-structured interviews to generate an initial item pool. An expert panel examined the content validity. We conducted a cross-sectional survey to evaluate scale reliability and validity. A total of 243 participants were recruited. Exploratory factor analyses were used to test the construct validity, and internal consistency and test-retest reliability were assessed. RESULTS: The expert panel determined that the SMOD-CA content validity index was satisfactory. The final 30-item scale consisted of four factors explaining 49.50% of the total variance in the data. Cronbach’s α was 0.901 for the total scale and 0.911 for test–retest reliability. CONCLUSIONS: The SMOD-CA demonstrated good reliability and validity. The scale is a credible and effective instrument that can be used by social workers and health care professionals to assess self-management in Chinese adults with type 1 diabetes. Trial registration number NCT03610984
format Online
Article
Text
id pubmed-7469726
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74697262020-09-16 Development and validation of a self-management scale of type 1 diabetes for Chinese adults Zhu, Song Liu, Fang Li, Jina Guan, Yuzhu Meng, Meng Li, Xia Zhou, Zhiguang Xu, Rong Li, Lezhi J Int Med Res Validation Study OBJECTIVE: Self-management is beneficial for improving health outcomes in adults with type 1 diabetes. However, there are no validated instruments to assess self-management in Chinese adults with type 1 diabetes. The aim of this study was to develop and validate the Self-Management of Type 1 Diabetes for Chinese Adults (SMOD-CA) scale. METHODS: Qualitative and quantitative methods were used to develop the SMOD-CA. We conducted a literature review and semi-structured interviews to generate an initial item pool. An expert panel examined the content validity. We conducted a cross-sectional survey to evaluate scale reliability and validity. A total of 243 participants were recruited. Exploratory factor analyses were used to test the construct validity, and internal consistency and test-retest reliability were assessed. RESULTS: The expert panel determined that the SMOD-CA content validity index was satisfactory. The final 30-item scale consisted of four factors explaining 49.50% of the total variance in the data. Cronbach’s α was 0.901 for the total scale and 0.911 for test–retest reliability. CONCLUSIONS: The SMOD-CA demonstrated good reliability and validity. The scale is a credible and effective instrument that can be used by social workers and health care professionals to assess self-management in Chinese adults with type 1 diabetes. Trial registration number NCT03610984 SAGE Publications 2020-08-31 /pmc/articles/PMC7469726/ /pubmed/32865059 http://dx.doi.org/10.1177/0300060520947588 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Validation Study
Zhu, Song
Liu, Fang
Li, Jina
Guan, Yuzhu
Meng, Meng
Li, Xia
Zhou, Zhiguang
Xu, Rong
Li, Lezhi
Development and validation of a self-management scale of type 1 diabetes for Chinese adults
title Development and validation of a self-management scale of type 1 diabetes for Chinese adults
title_full Development and validation of a self-management scale of type 1 diabetes for Chinese adults
title_fullStr Development and validation of a self-management scale of type 1 diabetes for Chinese adults
title_full_unstemmed Development and validation of a self-management scale of type 1 diabetes for Chinese adults
title_short Development and validation of a self-management scale of type 1 diabetes for Chinese adults
title_sort development and validation of a self-management scale of type 1 diabetes for chinese adults
topic Validation Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469726/
https://www.ncbi.nlm.nih.gov/pubmed/32865059
http://dx.doi.org/10.1177/0300060520947588
work_keys_str_mv AT zhusong developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT liufang developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT lijina developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT guanyuzhu developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT mengmeng developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT lixia developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT zhouzhiguang developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT xurong developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults
AT lilezhi developmentandvalidationofaselfmanagementscaleoftype1diabetesforchineseadults